Healthcare
Telomir Pharmaceuticals Unveils Groundbreaking Results with Telomir-1: A New Hope for Combating Oxidative Stress and Viral Infections
Innovative drug shows potential to address aging, chronic diseases, and avian influenza through oxidative stress reversal Telomir Pharmaceuticals (TELO), a...
Inspira Technologies: Revolutionizing Life-Support with First Deployments in Leading U.S. Hospital
Israeli Innovator Marks Milestone with Advanced Cardiopulmonary Bypass Systems Inspira Technologies (NASDAQ: IINN), a trailblazer in respiratory support technology, has...
Inspira Technologies Unveils Modular VORTX Blood Oxygenation System
Revolutionizing Respiratory Care for ICU Patients with Breakthrough Innovation Inspira Technologies (IINN) has announced a significant breakthrough in respiratory care...
Moderna Slashes 2025 Sales Forecast Amid Weak Vaccine Demand
Slow RSV shot adoption and waning COVID-19 vaccine sales weigh on revenue projections Moderna (MRNA) announced a $1 billion reduction...
Alpha Cognition Secures $44 Million Licensing Deal with CMS for ZUNVEYL in Asia-Pacific
Agreement Paves the Way for Advanced Alzheimer’s Treatment in China and Beyond Alpha Cognition (ACOG), a biopharmaceutical company at the...
Telomir Pharmaceuticals Unveils Groundbreaking Progeria Treatment in Preclinical Study
Novel Therapy Shows Promise in Restoring Lifespan and Addressing Accelerated Aging Telomir Pharmaceuticals (TELO), a leader in age-reversal science, has...
Traws Pharma Advances Bird Flu Treatment with Promising Phase 1 Results
Tivoxavir Marboxil Shows Potent Protection Against H5N1 in Preclinical and Early Clinical Studies Traws Pharma (TRAW), a clinical-stage biopharmaceutical company,...
Telomir Pharmaceuticals Advances Groundbreaking Research in Copper-Binding Therapies for Wilson’s Disease
Emerging Findings Position Telomir-1 as a Promising Solution for Copper Metabolism Disorders and Expand Its Potential Applications Telomir Pharmaceuticals (TELO),...
Novo Nordisk’s CagriSema Trial Results Shake Market Confidence
Disappointing Data Spurs $125 Billion Market Value Drop Novo Nordisk’s (NVO) ambitions in the competitive obesity drug market took a...
MIRA Pharmaceuticals Advances Ketamir-2: A Safe Step Forward in Neuropathic Pain Treatment
Favorable safety results pave the way for Phase 1 human trials in early 2025, offering hope for millions seeking non-addictive...
